Logo Logo
Hilfe
Hilfe
Switch Language to English

Zhang, Danmei; Kruger, Stephan; Schirle, Karoline; Heinemann, Volker; Dorman, Klara; Westphalen, Benedikt; Weiss, Lena; Gebauer, Leonie; Gunther, Michael; Ormanns, Steffen; Werner, Jens; Bergwelt-Baildon, Michael von; Boeck, Stefan und Haas, Michael (2022): Clinical impact of structured post-operative surveillance in resected pancreatic adenocarcinoma: Results from a retrospective cohort study. In: Oncology Research and Treatment, Bd. 46, Nr. 3: S. 106-115

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

IntroductionTo this date, surgery remains the only potentially curative approach in the treatment of pancreatic cancer. To analyse the clinical impact of a structured post-operative follow-up program, we retrospectively analysed a cohort of resected pancreatic adenocarcinoma patients treated at LMU Munich. MethodsPancreatic adenocarcinoma patients who underwent resection and presented for regular follow-up visits at our center between 2002 and 2017 were identified from two existing study cohorts. Diagnosis of recurrences was categorized by timing (within or outside a scheduled follow up visit) and detection modality (imaging, CA 19-9 increase, or clinical deterioration) and correlated with disease-free survival (DFS) and overall survival (OS). ResultsOne-hundred and twenty-five patients with resected pancreatic adenocarcinoma were included in this analysis. Median OS in the whole cohort was 21.1 months. Of these 125 patients, 103 (82.4%) had a documented relapse. Tumour recurrences detected within a scheduled follow up visit (n=86, 83.5%) compared to recurrences becoming apparent at an unplanned visit (n=17, 16.5%) were associated with a significantly improved OS (median 25.5 versus 20.2 months, p=0.019). Compared to patients with recurrence detected by clinical deterioration (n=4, 3.9%), patients with recurrences detected by imaging or laboratory abnormalities (n=99, 96.0%) had a longer median OS (24.8 versus 15.1 months, p=0.007). Disscusion/ConclusionA structured follow-up after PDAC resection may have an impact on patient outcome. Prospective trials are needed to evaluate the clinical impact of post-operative follow-up programs.

Dokument bearbeiten Dokument bearbeiten